Cangene
Cangene Corporation was a biopharmaceutical company based in Winnipeg, Manitoba, Canada. It specialized in the development, manufacture, and commercialization of specialty hyperimmune products, contract manufacturing, and biopharmaceuticals. Cangene was one of Canada's oldest and largest biopharmaceutical companies before it was acquired by Emergent BioSolutions in 2014.
History[edit | edit source]
Cangene was founded in 1984 and became a publicly traded company in 1991. The company focused on developing products derived from human plasma, including hyperimmune products used to treat infectious diseases and immune deficiencies. Over the years, Cangene expanded its product line and capabilities, including contract manufacturing services for other biopharmaceutical companies.
Products[edit | edit source]
Cangene's product portfolio included several key hyperimmune products:
- WinRho SDF - Used for the treatment of Rh disease in newborns and immune thrombocytopenic purpura (ITP).
- HepaGam B - Used for the prevention of hepatitis B recurrence following liver transplantation and for post-exposure prophylaxis.
- VariZIG - Used for the treatment of varicella zoster virus (chickenpox) in high-risk individuals.
- Vaccinia Immune Globulin Intravenous (VIGIV) - Used to treat complications from the smallpox vaccine.
Acquisition by Emergent BioSolutions[edit | edit source]
In 2014, Cangene was acquired by Emergent BioSolutions, a global life sciences company focused on providing specialty products for civilian and military populations that address accidental, intentional, and naturally occurring public health threats. The acquisition allowed Emergent BioSolutions to expand its product portfolio and manufacturing capabilities.
Facilities[edit | edit source]
Cangene operated several facilities, including its headquarters and primary manufacturing plant in Winnipeg, Manitoba. The company also had facilities in the United States, including a plasma collection center in Baltimore, Maryland.
See also[edit | edit source]
- Emergent BioSolutions
- Biopharmaceutical
- Hyperimmune globulin
- Rh disease
- Immune thrombocytopenic purpura
- Hepatitis B
- Varicella zoster virus
- Smallpox vaccine
References[edit | edit source]
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD